BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26430849)

  • 1. Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life.
    Sagberg LM; Solheim O; Jakola AS
    J Neurosurg; 2016 Apr; 124(4):989-97. PubMed ID: 26430849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative quality of life in functionally dependent glioblastoma patients: A prospective study.
    Jakola AS; Sagberg LM; Gulati S; Solheim O
    Br J Neurosurg; 2015; 29(6):843-9. PubMed ID: 26098603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients with intracranial tumors: does tumor laterality matter?
    Drewes C; Sagberg LM; Jakola AS; Solheim O
    J Neurosurg; 2016 Dec; 125(6):1400-1407. PubMed ID: 27015402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with intracranial gliomas: the impact of modern image-guided surgery.
    Jakola AS; Unsgård G; Solheim O
    J Neurosurg; 2011 Jun; 114(6):1622-30. PubMed ID: 21314270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
    Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
    World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival prognostic factors in patients with glioblastoma: our experience.
    Raysi Dehcordi S; De Paulis D; Marzi S; Ricci A; Cimini A; Cifone MG; Galzio RJ
    J Neurosurg Sci; 2012 Sep; 56(3):239-45. PubMed ID: 22854592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.
    Taphoorn MJB; Dirven L; Kanner AA; Lavy-Shahaf G; Weinberg U; Taillibert S; Toms SA; Honnorat J; Chen TC; Sroubek J; David C; Idbaih A; Easaw JC; Kim CY; Bruna J; Hottinger AF; Kew Y; Roth P; Desai R; Villano JL; Kirson ED; Ram Z; Stupp R
    JAMA Oncol; 2018 Apr; 4(4):495-504. PubMed ID: 29392280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative and Postoperative Quality of Life in Patients with Glioma-A Longitudinal Cohort Study.
    Drewes C; Sagberg LM; Jakola AS; Solheim O
    World Neurosurg; 2018 Sep; 117():e465-e474. PubMed ID: 29920391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between preoperative cervical sagittal deformity and inferior outcomes at 2-year follow-up in patients with adult thoracolumbar deformity: analysis of 182 patients.
    Scheer JK; Passias PG; Sorocean AM; Boniello AJ; Mundis GM; Klineberg E; Kim HJ; Protopsaltis TS; Gupta M; Bess S; Shaffrey CI; Schwab F; Lafage V; Smith JS; Ames CP;
    J Neurosurg Spine; 2016 Jan; 24(1):108-15. PubMed ID: 26360147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study.
    Jakola AS; Gulati S; Weber C; Unsgård G; Solheim O
    PLoS One; 2011; 6(12):e28592. PubMed ID: 22174842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of transsphenoidal surgery for pituitary adenomas on overall health-related quality of life: a longitudinal cohort study.
    Sommerfelt H; Sagberg LM; Solheim O
    Br J Neurosurg; 2019 Dec; 33(6):635-640. PubMed ID: 31544528
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the minimum clinically important difference in pain, disability, and quality of life after anterior cervical discectomy and fusion: clinical article.
    Parker SL; Godil SS; Shau DN; Mendenhall SK; McGirt MJ
    J Neurosurg Spine; 2013 Feb; 18(2):154-60. PubMed ID: 23176164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life following surgical treatment of lesions within the pineal region.
    Fedorko S; Zweckberger K; Unterberg AW
    J Neurosurg; 2018 Mar; 130(1):28-37. PubMed ID: 29498568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary versus recurrent surgery for glioblastoma-a prospective cohort study.
    Rubin MC; Sagberg LM; Jakola AS; Solheim O
    Acta Neurochir (Wien); 2022 Feb; 164(2):429-438. PubMed ID: 33052493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients.
    Pompili A; Telera S; Villani V; Pace A
    Neurosurg Focus; 2014 Dec; 37(6):E5. PubMed ID: 25434390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trial.
    Dirven L; van den Bent MJ; Bottomley A; van der Meer N; van der Holt B; Vos MJ; Walenkamp AM; Beerepoot LV; Hanse MC; Reijneveld JC; Otten A; de Vos FY; Smits M; Bromberg JE; Taal W; Taphoorn MJ;
    Eur J Cancer; 2015 Jul; 51(10):1321-30. PubMed ID: 25899986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.